UGUniversity of Georgia · Microbiology & Immunology
Quinn Lab
Frederick D Quinn · Athens, Georgia
Research Focus
Dr. Frederick D. Quinn's lab at the University of Georgia focuses on developing novel vaccines to combat respiratory infections, particularly tuberculosis. Using advanced nanoparticle technology, the lab is researching ways to stimulate local immune responses in the lungs to provide better protection against diseases caused by inhaled pathogens. By combining multiple mycobacterial proteins with immune-boosting components, they aim to create a more effective vaccine that builds on existing methods.
tuberculosismucosal vaccinenanoparticlesimmune responsemycobacterium tuberculosis
Research Aims
3AIM 01Develop a nanoparticle-based mucosal vaccine for tuberculosis
AIM 02Evaluate immune responses to various vaccine formulations
AIM 03Assess safety and efficacy of the best vaccine candidates in animal models
Skills the Lab Values
cell cultureimmune response assessmentanimal modelsvaccination techniquesnanoparticle formulation
Output against the department
Publications104bottom 37% of dept.303rd of 486
this lab
most publishedleast published
Citations8.4ktop 43% of dept.208th of 486
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.